Reversed-role chemotherapy for resistant cancer. (Q54421038)

29 May 2018

title

Reversed-role chemotherapy for resistant cancer. (English)

1 reference

29 May 2018

1 reference

K D Bagshawe

1

1 reference

29 May 2018

language of work or name

English

0 references

publication date

1 October 1986

1 reference

29 May 2018

published in

The Lancet

1 reference

29 May 2018

volume

2

1 reference

29 May 2018

issue

8510

1 reference

29 May 2018

page(s)

778-781

1 reference

29 May 2018

Genetic implication of karyological instability of malignant somatic cells

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Amplification of Dihydrofolate Reductase Genes in Methotrexate-resistant Cultured Mouse Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Therapeutic effects of hydroxyurea.Experience with 118 patients with inoperable solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Rapid fluorometric detection of drug resistant tumour cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

A method to measure the duration of DNA synthesis and the potential doubling time from a single sample

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Studies in the mouse of the pharmacology of 5-iododeoxyuridine, an analogue of thymidine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

5-iodo-2'-deoxyuridine and DNA synthesis in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Suppression of Infections Resulting from a Deoxyribonucleic Acid Virus (Vaccinia) By Systemic Administration of 5-Iodo-2′-Deoxyuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

DELETION OF THYMIDINE KINASE ACTIVITY FROM L CELLS RESISTANT TO BROMODEOXYURIDINE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Genetics of human cell lines. III. Incorporation of 5-bromo- and 5-iododeoxyuridine into the deoxyribonucleic acid of human cells and its effect on radiation sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Repair Replication and Degradation of Bromouracil-Substituted DNA in Mammalian Cells after Irradiation with Ultraviolet Light

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Enhanced killing of HeLa cells pre-labeled with 5-bromodeoxyuridine by monochromatic synchrotron radiation at 0.9 A: an evidence for Auger enhancement in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Inactivation of Mammalian Cells after Disintegrations of3H or125I in Cell DNA at −196°C

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

In vivo effects of methotrexate. Inhibition of DNA synthesis and cell death in sensitive and resistant L1210 ascites populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Modulation of 5-iodo-2'-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Cancer drug targeting.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

Tumour growth and anti-mitotic action. The role of spontaneous cell losses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990301-6

7 January 2021

10.1016/S0140-6736(86)90301-6

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018